drugset / Trial / NCT01063556
Pharmacokinetics Study of Donepezil HCl in Subjects Receiving Haemodialysis.
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to investigate the pharmacokinetics of donepezil HCl 3 mg in subjects with end-state renal disease who were receiving haemodialysis.
Timeline
- Start
- 2010-02
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | 3 mg | — |